Disc Medicine, Inc. Earnings Per Share (Basic)
Disc Medicine, Inc. (IRON) reported Earnings Per Share (Basic) of -$1.54 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-30
- Disc Medicine, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.54.
- Disc Medicine, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.65.
- Disc Medicine, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$1.77.
- Disc Medicine, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$1.58.
- Disc Medicine, Inc. earnings per share, basic for fiscal 2025 was -$6.01.
- Disc Medicine, Inc. earnings per share, basic for fiscal 2024 was -$3.96.
- Disc Medicine, Inc. earnings per share, basic for fiscal 2023 was -$3.42.
- Disc Medicine, Inc. earnings per share, basic for fiscal 2022 was -$45.05.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.54 10-Q · filed 2026-07-30 | -$3.19 10-Q · filed 2026-07-30 | |||||
| 2026-03-31 | -$1.65 10-Q · filed 2026-05-05 | ||||||
| 2025-12-31 | -$6.01 10-K · filed 2026-02-26 | ||||||
| 2025-09-30 | -$1.77 10-Q · filed 2025-11-06 | -$4.39 10-Q · filed 2025-11-06 | |||||
| 2025-06-30 | -$1.58 10-Q · filed 2026-07-30 | -$2.61 10-Q · filed 2026-07-30 | |||||
| 2025-03-31 | -$1.02 10-Q · filed 2026-05-05 | ||||||
| 2024-12-31 | -$3.96 10-K · filed 2026-02-26 | ||||||
| 2024-09-30 | -$0.89 10-Q · filed 2025-11-06 | -$1.91 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$2.98 10-Q · filed 2025-11-06 | -$3.95 derived: net income ÷ weighted average shares · filed 2026-02-26 | |||
| 2024-06-30 | -$1.03 10-Q · filed 2025-08-07 | -$2.11 10-Q · filed 2025-08-07 | -$3.08 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$3.67 derived: net income ÷ weighted average shares · filed 2026-02-26 | |||
| 2024-03-31 | -$1.09 10-Q · filed 2025-05-07 | -$2.05 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$2.64 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$3.39 derived: net income ÷ weighted average shares · filed 2026-02-26 | |||
| 2023-12-31 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.55 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$2.29 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$3.42 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$0.58 10-Q · filed 2024-11-12 | -$1.31 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$2.45 10-Q · filed 2024-11-12 | -$3.88 derived: net income ÷ weighted average shares · filed 2024-11-12 | |||
| 2023-06-30 | -$0.74 10-Q · filed 2024-08-08 | -$1.91 10-Q · filed 2024-08-08 | -$3.59 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$6.19 derived: net income ÷ weighted average shares · filed 2024-08-08 | |||
| 2023-03-31 | -$1.20 10-Q · filed 2024-05-09 | -$3.35 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$7.09 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$10.77 derived: net income ÷ weighted average shares · filed 2024-05-09 | |||
| 2022-12-31 | -$8.46 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$23.93 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$34.30 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$45.05 10-K · filed 2024-03-21 | |||
| 2022-09-30 | -$16.82 10-Q · filed 2023-11-09 | -$0.08 10-Q · filed 2022-11-10 | -$27.01 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$37.73 10-Q · filed 2023-11-09 | -$0.59 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | -$10.14 10-Q · filed 2023-08-11 | -$0.16 10-Q · filed 2022-08-11 | -$20.80 10-Q · filed 2023-08-11 | -$0.52 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | -$10.67 10-Q · filed 2023-05-15 | ||||||
| 2021-12-31 | -$40.95 10-K · filed 2023-03-31 | ||||||
| 2021-09-30 | -$0.43 10-Q · filed 2022-11-10 | -$1.37 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$0.38 10-Q · filed 2022-08-11 | -$0.94 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |